Almac Discovery and Queen’s University Belfast’s Centre for Cancer Research and Cell Biology (CCRCB) have launched a $20 million cancer drug discovery partnership to accelerate cancer-focused drug discovery in Northern Ireland. As part of the project, Queen’s and Almac have scheduled a Phase I clinical trial for ovarian cancer involving the first novel cancer drug fully developed in Northern Ireland. The drug was created as a result of an earlier collaboration between Almac Discovery and Profess...